Innate immunity in systemic sclerosis
Author:
Open Access
- 27 May 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 201 (1) , 12-13
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantationClinical and Experimental Immunology, 2020
- Novel insights into dendritic cells in the pathogenesis of systemic sclerosisClinical and Experimental Immunology, 2020
- Toll-like receptors in mediating pathogenesis in systemic sclerosisClinical and Experimental Immunology, 2020
- Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosisAnnals of the Rheumatic Diseases, 2019
- Innate Immunity in Systemic SclerosisCurrent Rheumatology Reports, 2017
- Role of innate immune system in systemic sclerosisSeminars in Immunopathology, 2015
- Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic SclerosisJAMA, 2014
- Fibronectin EDA Promotes Chronic Cutaneous Fibrosis Through Toll-Like Receptor SignalingScience Translational Medicine, 2014
- Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factorsAnnals of the Rheumatic Diseases, 2013